NVCT (NVCT) Stock Price & Analysis
NVCT (NVCT) rose 0.00% to USD 19.31 as of July 26, 2026 at 12:46 UTC, according to Nexqual real-time market data.
NVCT last closed at USD 19.31; the session ranged USD 19.04–20.2 on volume of 245,631 shares. Market capitalization is —, with a 52-week range of USD 5.55–29.28 (NCM). Source: Nexqual, July 26, 2026 at 12:46 UTC.
Key Statistics (as of July 26, 2026 at 12:46 UTC)
| Price | USD 19.31 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 19.31 |
| Open | USD 19.31 |
| Day Range | USD 19.04 – 20.2 |
| 52-Week Range | USD 5.55 – 29.28 |
| Volume | 245,631 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (NVCT)
Nexqual's technical model rates NVCT "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 26, 2026 at 12:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.8 (neutral) |
| vs SMA50 | Above (USD 15.22) |
| MACD | 0.96 (positive) |
From NVCT's Latest SEC 10-K Filing (filed 2026-02-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IMMX | Immix Biopharma, Inc. | USD 8.52 | ▼ 9.46% |
| NRSN | NeuroSense Therapeutics Ltd. | USD 0.6 | ▼ 7.38% |
| ANGH | Anghami Inc. | USD 3.39 | ▲ 1.8% |
| TRDA | Entrada Therapeutics, Inc. | USD 5.85 | ▼ 4.88% |
| FHTX | Foghorn Therapeutics Inc. | USD 4.85 | ▼ 6.91% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 12:46 UTC. This page is informational and not investment advice.